Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

cilazaprilat

Known as: cilazaprilat anhydrous 
The active metabolite of cilazapril, a pyridazine angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
The present study was undertaken to clarify the role of intrarenal angiotensin (Ang) II and its generating pathways in clipped… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Highly Cited
1999
Highly Cited
1999
BACKGROUND Although ACE inhibitors can protect myocardium against ischemia/reperfusion injury, the mechanisms of this effect have… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1998
Highly Cited
1998
To elucidate the local effects of renin in the coronary circulation, we examined local angiotensin (Ang) I and II formation, as… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 5
1998
1998
A rapid and simple high-performance liquid chromatographic method with amperometric detection has been developed for the… Expand
Highly Cited
1995
Highly Cited
1995
BACKGROUND Angiotensin-converting enzyme (ACE) produces angiotensin II, causing vasoconstriction of coronary arteries and… Expand
Highly Cited
1992
Highly Cited
1992
Studies were designed to investigate the mechanisms underlying the augmentation by angiotensin I converting enzyme (ACE… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1992
1992
1. The pharmacokinetic and pharmacodynamic responses to enalapril, perindopril and cilazapril have been studied in essential… Expand
Highly Cited
1991
Highly Cited
1991
The effects of cilazaprilat were assessed on endothelium-dependent relaxations and contractions in isolated canine arteries. In… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Highly Cited
1987
Highly Cited
1987
Summary: Cilazapril 1.25 and 5.0 mg p.o. q.d. was administered in double-blind fashion to two groups of six normal volunteers on… Expand
Highly Cited
1987
Highly Cited
1987
Summary: The pharmacokinetics of the new converting enzyme inhibitor cilazapril were investigated in 12 healthy male volunteers… Expand